» Articles » PMID: 38887038

Investigating the Potential of Multilineage Differentiating Stress-Enduring Cells for Osteochondral Healing

Overview
Journal Cartilage
Date 2024 Jun 18
PMID 38887038
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Multilineage differentiating stress-enduring (Muse) cells, a pluripotent stem cell subset of mesenchymal stem cells (MSCs), have shown promise for various tissue repairs due to their stress tolerance and multipotent capabilities. We aimed to investigate the differentiation potential , the dynamics , and the reparative contribution of Muse cells to osteochondral lesions.

Design: Labeled MSCs were cultured and sorted into Muse and non-Muse (MSCs without Muse cells) groups. These cells were then formed into spheroids, and chondrogenic differentiation was assessed . Twenty-one immunocompromised mice were used as the models of osteochondral lesions. Live imaging, macroscopic evaluation, and histological and immunohistochemical analyses were conducted at the 4- and 8-week time points.

Results: Muse cell spheroids were formed, which were larger and stained more intensely with toluidine blue than non-Muse spheroids, indicating better chondrogenic differentiation. Live imaging confirmed luminescence in all 4-week model knees, but only in a few knees at 8 weeks, suggesting cell persistence. Macroscopically and histologically, no significant differences were observed between the Muse and non-Muse groups at 4 and 8 weeks; however, both groups showed better cartilage repair than that of the vehicle group at 8 weeks. No collagen type II generation was observed in the repaired tissues.

Conclusion: The implantation of the spheroids of Muse and non-Muse cells resulted in better healing of osteochondral lesions than that of the controls, and Muse cells had a higher chondrogenic differentiation potential than non-Muse cells.

References
1.
Okamura G, Ebina K, Hirao M, Chijimatsu R, Yonetani Y, Etani Y . Promoting Effect of Basic Fibroblast Growth Factor in Synovial Mesenchymal Stem Cell-Based Cartilage Regeneration. Int J Mol Sci. 2021; 22(1). PMC: 7796036. DOI: 10.3390/ijms22010300. View

2.
Hunziker E . Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage. 2002; 10(6):432-63. DOI: 10.1053/joca.2002.0801. View

3.
Yoon K, Park J, Lee J, Lee E, Lee J, Kim S . Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation for Treatment of Articular Cartilage Defect. Am J Sports Med. 2020; 48(5):1236-1245. DOI: 10.1177/0363546520905565. View

4.
Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A . Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res. 2000; (374):212-34. DOI: 10.1097/00003086-200005000-00020. View

5.
Phinney D, Pittenger M . Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells. 2017; 35(4):851-858. DOI: 10.1002/stem.2575. View